Geron Corp. (GERN)
0.9905
0.00 (0.00%)
USD |
NASDAQ |
Nov 09, 16:00
0.9905
0.00 (0.00%)
After-Hours: 19:29
Geron Price to Book Value : 2.815 for Nov. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 2.813 |
| November 05, 2026 | 2.700 |
| November 04, 2026 | 3.069 |
| November 03, 2026 | 2.643 |
| November 02, 2026 | 2.640 |
| October 30, 2026 | 2.542 |
| October 29, 2026 | 2.689 |
| October 28, 2026 | 2.752 |
| October 27, 2026 | 3.268 |
| October 26, 2026 | 3.268 |
| October 23, 2026 | 3.183 |
| October 22, 2026 | 3.211 |
| October 21, 2026 | 3.297 |
| October 20, 2026 | 3.524 |
| October 19, 2026 | 3.410 |
| October 16, 2026 | 3.325 |
| October 15, 2026 | 3.496 |
| October 14, 2026 | 3.382 |
| October 13, 2026 | 3.410 |
| October 12, 2026 | 3.467 |
| October 09, 2026 | 3.481 |
| October 08, 2026 | 3.467 |
| October 07, 2026 | 3.410 |
| October 06, 2026 | 3.439 |
| October 05, 2026 | 3.439 |
| Date | Value |
|---|---|
| October 02, 2026 | 3.410 |
| October 01, 2026 | 3.439 |
| September 30, 2026 | 3.496 |
| September 29, 2026 | 3.644 |
| September 28, 2026 | 3.674 |
| September 25, 2026 | 3.703 |
| September 24, 2026 | 3.703 |
| September 23, 2026 | 3.644 |
| September 22, 2026 | 3.850 |
| September 21, 2026 | 3.820 |
| September 18, 2026 | 3.820 |
| September 17, 2026 | 3.879 |
| September 16, 2026 | 3.791 |
| September 15, 2026 | 3.850 |
| September 14, 2026 | 4.026 |
| September 11, 2026 | 3.967 |
| September 10, 2026 | 4.026 |
| September 09, 2026 | 4.114 |
| September 08, 2026 | 4.438 |
| September 04, 2026 | 4.614 |
| September 03, 2026 | 4.438 |
| September 02, 2026 | 4.673 |
| September 01, 2026 | 4.350 |
| August 31, 2026 | 4.379 |
| August 28, 2026 | 4.438 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.53 |
| Anika Therapeutics, Inc. | 1.416 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 0.9579 |
Price to Book Value Related Metrics
| PS Ratio | 3.052 |
| Price | 0.9905 |
| Earnings Yield | -7.57% |
| Market Cap | 636.37M |